CosmoFarm Hits $15M Q2 Revenue, Expands Pharmacy Network and AI Automation
Event summary
- CosmoFarm, a subsidiary of Cosmos Health Inc., reported $15M+ revenue in Q2 2026, annualizing to $60M+ run-rate.
- Added over 80 pharmacies to its distribution network in the greater Athens area.
- Investing in robotic automation and AI systems to enhance procurement, inventory management, and order fulfillment.
- Expanding facility capacity to support higher volumes and continued network expansion.
The big picture
CosmoFarm's record Q2 revenue underscores the strategic importance of vertical integration in pharmaceutical distribution. The company's focus on AI-driven automation aligns with broader industry trends toward operational efficiency and data-driven decision-making. With a growing pharmacy network and expanding facility capacity, Cosmos Health is positioning CosmoFarm to capitalize on the increasing demand for streamlined pharmaceutical supply chains in Europe.
What we're watching
- Scaling Efficiency
- How the integration of new robotic automation and AI systems will impact operational efficiency and margins.
- Market Expansion
- Whether CosmoFarm can sustain its rapid pharmacy network growth in the competitive Athens market.
- Capital Expenditure
- The pace at which increased capital expenditure will translate into scalable profitability.
Related topics